Methodology

D3 Bio (Wuxi) Co., Ltd – 7/22/2025

By /

FDA orphan drug designation: treatment of colorectal cancer (CRC) harboring KRAS p.G12C mutant protein

Facebook Linkedin
Main Menu
Scroll to Top